Gilead Sciences S.R.O. is the Czech affiliate of Gilead Sciences, responsible for commercial, medical, regulatory and pharmacovigilance activities in the Czech Republic. It supports the distribution and appropriate clinical use of Gilead's portfolio of innovative antiviral, liver disease, oncology, cell therapy and inflammatory disease medicines. The company collaborates with hospitals, clinics, healthcare professionals and national institutions to ensure patient access to modern therapies and participates in clinical research and post marketing surveillance activities. Key assets include Gilead's global innovation portfolio, local medical and regulatory teams and a developed network of healthcare partnerships. Strategically, Gilead Sciences S.R.O. positions itself as a specialised biopharmaceutical organisation focused on delivering advanced therapies for serious chronic and life threatening diseases.
Headquarters
Pujmanove 1753/10
Prague; The City of Prague;
Postal Code: 14000
Contact Details: Purchase the Gilead Sciences S.R.O. report to view the information.
Website: https://www.gilead.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service